Supplier News
Fujifilm Opens New $9-Million Cell Culture Labs in UK
The new 10,000 ft2 of laboratories will be dedicated to the company’s monoclonal antibody platform, which enables rapid access to development and manufacturing capacity.
Lonza, Portola Pharmaceuticals Sign Manufacturing Agreement
Lonza and Portola Pharmaceuticals have entered into a supply agreement for AndexXa (andexanet alfa), a recombinant protein used in patients on FXa inhibitors who experience a major bleed or need urgent surgery.
Recipharm and Kancera Collaborate on Development and Manufacture of Cancer Drug
Kancera’s drug candidate KAND567 will be developed as a capsule formulation for oral administration. Work will be performed at Recipharm’s development facility in Solna, Sweden.
Sartorius Opens New Manufacturing Facility for Lab Instruments
The new building is protected by special construction against vibration to ensure accurate calibration of laboratory balances.
Oxford Genetics Opens First US Office
The company has extended its presence in the US market to support its growing business in the region.
PPS Appoints New COO
Piramal Pharma Solutions (PPS), part of Piramal Enterprises, has appointed John Fowler as its COO.
FDA Issues Warning Letter to EpiPen Manufacturer
FDA cited Meridian Medical Technologies, a Pfizer company, which manufactures Mylan’s EpiPen, for cGMP violations that included failure to appropriately investigate defects in auto-injector components.
HTG Molecular Diagnostics to Complete FDA Filing for Gene Assay
HTG, a company that provides molecular profiling services, expects to complete submission of its premarket approval application to FDA for an in vitro gene assay by 2018.
Ventria to Double Biomanufacturing Capacity
The biopharmaceutical company broke ground on what will be a new 3000-ft2 addition to its Kansas biomanufacturing facility.
PCMM, The Next Generation
The Portable, Continuous, Miniature, and Modular (PCMM) collaboration is alive and well, and the second generation of its modular continuous manufacturing equipment is now available.
OSI and Petasense to Collaborate on IoT Solutions
Predictive maintenance is one application planned for a new alliance that will bring Internet of Things capability to users of OSI's PI solution.
Alcami to Establish API Center of Excellence
Alcami has announced the development of a Center of Excellence at its API development and manufacturing facility in Germantown, WI.
GE’s Thawing Technology for Delivering Cell Therapies
The VIA Thaw CB1000 from GE Healthcare offers thawing for large volumes of cell therapies cryopreserved in cryo-bags for research laboratories.
AMRI Acquired by The Carlyle Group and GTCR
The Carlyle Group and GTCR have completed a previously announced acquisition of AMRI, a contract research and manufacturing organization.
Catalent Signs Manufacturing Agreement with US WorldMeds
Catalent and US WorldMeds have entered into an agreement for the commercial manufacture of lofexidine, a drug used to alleviate opioid withdrawal symptoms.
Roquette Acquires Itacel
Roquette has completed its previously announced acquisition of Itacel, an excipient division of Blanver.
CRB Licenses Fluorescent Peptide Dyes from University of Edinburgh
Cambridge Research Biochemicals (CRB), a supplier of peptide and antibody research reagents, has licensed new fluorescent dyes from the University of Edinburgh that enhance live-cell imaging.
Avista Pharma Appoints Eric Evans as CFO
Avista Pharma has appointed Eric Evans as CFO.
Explosions Rock Arkema’s Texas Peroxides Plant
Faced with unprecedented flooding from Hurricane Harvey and days of persistent rain, Arkema’s Crosby, TX, plant lost all power, causing flammable chemicals to ignite.
MilliporeSigma Collaborates with Angiex on Cancer Drug
MilliporeSigma announced a collaboration with Angiex, a biotechnology start-up, to support the development of Angiex’s lead oncology antibody drug candidate to clinical use.
Lonza Expands Capabilities for Drug Product Services
Lonza is expanding parenteral dosage development capability and capacity in its Drug Product Services (DPS) sector at the company’s Basel, Switzerland facility.
Corden Pharma Facility in Italy is Cleared by FDA
An FDA evaluation concluded that Corden Pharma Latina’s corrective actions addressed the concerns in an FDA warning letter.
Siemens and ISA Partnership Fosters Cybersecurity Awareness
The International Society of Automation (ISA) and Siemens entered a global partnership to increase awareness of industrial cybersecurity needs and standards.
Cambrex Invests in Analytical Laboratory Expansion
Cambrex will expand its High Point, NC, facility with a $3.2-million, 11,000 ft.2 analytical laboratory.
Thermo Fisher Scientific Acquires Patheon
Thermo Fisher Scientific has completed the previously announced acquisition of Patheon for approximately $7.2 billion.
Circa and iFormulate Collaborate to Launch Biosolvant
Circa Group, a biotechnology company, has announced a collaboration with formulation science consultancy iFormulate to launch Cyrene, a biosolvent.
Merck KGaA’s MilliporeSigma to Acquire Natrix
MilliporeSigma, the life-science subsidiary of Merck KGaA, announced an agreement to acquire Natrix Separations, an Ontario, Canada-based provider of hydrogel membrane products for single-use chromatography.
Aseptic Fill/Finish Line for Drug Product Manufacturing
Ajinomoto Althea’s Optima VFVM 7000 aseptic fill/finish line supports a range of drug substance APIs.
Roquette Continues Investments with New R&D Facility
Roquette, a biopharmaceutical company specializing in plant-based excipients, announced the opening of a new R&D and customer technical service facility in Singapore in fall 2017.
AstraZeneca and Champions Oncology Partner on Xenograft R&D Models
AstraZeneca and Champions will develop new cohorts of patient-derived xenograft models to be used in oncology programs in breast and lung cancer as well as for use in other academic and industry applications.
